Moderna Says FDA Needs More Time to Assess Vaccine for Teens

Moderna Inc. said it was notified the U.S. Food and Drug Administration will require additional time to assess the company's emergency request to approve its Covid-19 vaccine for children ages 12 to 17 as regulators examine the risk of a rare heart ...

from Google Alert - Business https://ift.tt/3kd9HeD
Moderna Inc. said it was notified the U.S. Food and Drug Administration will require additional time to assess the company's emergency request to approve its Covid-19 vaccine for children ages 12 to 17 as regulators examine the risk of a rare heart ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize